This rapid point of care test provides results in just 10 minutes enabling patients to learn their status in a single visit. Syphilis positive patients can be connected to care while a lab test is completed for confirmed diagnosis.
It is important to note that this test offers an entirely new way screen for syphilis, yielding highly sensitive and specific results at the point of care. The test allows providers to get a result right away rather than waiting for a lab test to initiate care and counseling. Immediate steps can be taken with positive results to mitigate additional spread of syphilis.
Highly accurate: 98.0% sensitivity, 97.2% specificity; reads for both IgM and IgG.
CLIA-waived for fingerstick whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics. Ideal for both clinical and non-clinical settings.
The test is not intended for use in screening blood or plasma donors.
This test does not require a reader or additional equipment. Providers can batch tests, enabling more people to get tested, reducing indirect costs and improving turnaround time.
Can be used with people ages 13 years and older.
Studies have verified the accuracy at all stages of infection including latent, which provides the ability to detect infection in pregnant people for identification of potential congenital syphilis at every trimester.
Pricing is based on shipping location and the number of units ordered. To request a price, please use the Request a Quote button below. A sales representative will respond to you quickly.
This rapid point of care test provides results in just 10 minutes enabling patients to learn their status in a single visit. Syphilis positive patients can be connected to care while a lab test is completed for confirmed diagnosis.
It is important to note that this test offers an entirely new way screen for syphilis, yielding highly sensitive and specific results at the point of care. The test allows providers to get a result right away rather than waiting for a lab test to initiate care and counseling. Immediate steps can be taken with positive results to mitigate additional spread of syphilis.
Highly accurate: 98.0% sensitivity, 97.2% specificity; reads for both IgM and IgG.
CLIA-waived for fingerstick whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics. Ideal for both clinical and non-clinical settings.
The test is not intended for use in screening blood or plasma donors.
This test does not require a reader or additional equipment. Providers can batch tests, enabling more people to get tested, reducing indirect costs and improving turnaround time.
Can be used with people ages 13 years and older.
Studies have verified the accuracy at all stages of infection including latent, which provides the ability to detect infection in pregnant people for identification of potential congenital syphilis at every trimester.